Raab & Moskowitz Asset Management’s Biogen BIIB Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-720	Closed	-$227K	–	135
2020 Q1	$227K	Buy	720 +16	+2%	+$4.86K	0.12%	127
2019 Q4	$208K	Buy	+704	New	+$195K	0.08%	155
2019 Q1	–	Sell	-714	Closed	-$214K	–	164
2018 Q4	$214K	Hold	714	–	–	0.11%	152
2018 Q3	$252K	Hold	714	–	–	0.1%	142
2018 Q2	$207K	Buy	+714	New	+$201K	0.1%	160
2015 Q1	–	Sell	-258	Closed	-$88K	–	140
2014 Q4	$88K	Buy	+258	New	+$83.5K	0.05%	147

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raab & Moskowitz Asset Management's BIIB Position: Q2 2020 in Review

Raab & Moskowitz Asset Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 720 shares — an estimated $227K sold.

Raab & Moskowitz Asset Management first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $252K in Q3 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Raab & Moskowitz Asset Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 720 Biogen shares in Q2 2020, an estimated $227K.
Raab & Moskowitz Asset Management first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
Raab & Moskowitz Asset Management's Biogen position peaked at $252K in Q3 2018.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.